Resolution of Longstanding Symptoms of Multiple Sclerosis by Application of Picotesla Range Magnetic Fields
Recent clinical reports have suggested that treatment with extremely weak magnetic fields (MF) in the PicoTesla range is an efficacious modality for the symptomatic therapy in patients with multiple sclerosis IZMS) during the remission and exacerbation periods of the disease. The present communicati...
Gespeichert in:
Veröffentlicht in: | International journal of neuroscience 1993, Vol.70 (3-4), p.255-269 |
---|---|
Hauptverfasser: | , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Recent clinical reports have suggested that treatment with extremely weak magnetic fields (MF) in the PicoTesla range is an efficacious modality for the symptomatic therapy in patients with multiple sclerosis IZMS) during the remission and exacerbation periods of the disease. The present communication concerns a 64 year old woman with a 22 year history of MS of the chronic-progressive type who presented with a longstanding history of ataxia of gait, weakness in the legs, difficulties with swallowing, loss of bladder control, blurred vision, diplopia, chronic fatigue, and cognitive impairment. In this patient two 30 minute treatments with MF on two separate days resulted in a dramatic improvement of symptoms. Specifically, the patient experienced marked improvement in balance and gait as well as increased strength in the legs to the extent that she was able to abandon the use of a walker within 48 hours after initiation of magnetic treatment. In addition, there was complete resolution of diplopia, bladder dysfunction, and fatigue with improvement in mood and cognitive functions. The report attests to the unique efficacy of extremely weak MF in the symptomatic treatment of patients with MS including those patients with a chronic progressive course of the disease and supports the hypothesis that dysfunction of synaptic conductivity due to neurotransmitter deficiency specifically of serotonin rather than demyelination underlies the neurologic deficils of the disease |
---|---|
ISSN: | 0020-7454 1563-5279 1543-5245 |
DOI: | 10.3109/00207459309000580 |